Skip to content

Author

Yongbo Zou

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer

A ferroptosis- and lipid metabolism-related prognostic signature is developed that accurately predicts survival outcomes and immune characteristics in CRC and CRY2 was identified as a critical regulator of tumor growth.

Yu Guo, Yongbo Zou, Min Wang · 0 citations